These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38382829)

  • 1. Vascular stent with immobilized anti-inflammatory chemerin 15 peptides mitigates neointimal hyperplasia and accelerates vascular healing.
    Wen L; Qiu H; Li S; Huang Y; Tu Q; Lyu N; Mou X; Luo X; Zhou J; Chen Y; Wang C; Huang N; Xu J
    Acta Biomater; 2024 Apr; 179():371-384. PubMed ID: 38382829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
    Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
    J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct surface modification of metallic biomaterials via tyrosine oxidation aiming to accelerate the re-endothelialization of vascular stents.
    Kakinoki S; Takasaki K; Mahara A; Ehashi T; Hirano Y; Yamaoka T
    J Biomed Mater Res A; 2018 Feb; 106(2):491-499. PubMed ID: 28975703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization.
    Kleinedler JJ; Foley JD; Orchard EA; Dugas TR
    J Control Release; 2012 Apr; 159(1):27-33. PubMed ID: 22269665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ta ion implanted nanoridge-platform for enhanced vascular responses.
    Jang TS; Lee JH; Kim S; Park C; Song J; Jae HJ; Kim HE; Chung JW; Jung HD
    Biomaterials; 2019 Dec; 223():119461. PubMed ID: 31518843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
    Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
    Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An electrospun fiber-covered stent with programmable dual drug release for endothelialization acceleration and lumen stenosis prevention.
    Zhang Y; Wang J; Xiao J; Fang T; Hu N; Li M; Deng L; Cheng Y; Zhu Y; Cui W
    Acta Biomater; 2019 Aug; 94():295-305. PubMed ID: 31195144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multiple roles of chemokines in the mechanisms of stent biocompatibility.
    Ravindran D; Karimi Galougahi K; Tan JTM; Kavurma MM; Bursill CA
    Cardiovasc Res; 2021 Sep; 117(11):2299-2308. PubMed ID: 32196069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
    He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin promotes intimal hyperplasia and contributes to in-stent restenosis: Role of an αVβ3/FAK dependent YAP pathway.
    He Y; Zou P; Lu Y; Jia D; Li X; Yang H; Tang L; Zhu Z; Tu T; Tai S; Xiao Y; Chen M; Lu L; Zhou S
    J Mol Cell Cardiol; 2020 Feb; 139():1-13. PubMed ID: 31958462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-Endothelialization Study on Endovascular Stents Seeded by Endothelial Cells through Up- or Downregulation of VEGF.
    Wu X; Zhao Y; Tang C; Yin T; Du R; Tian J; Huang J; Gregersen H; Wang G
    ACS Appl Mater Interfaces; 2016 Mar; 8(11):7578-89. PubMed ID: 26925508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
    van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nitric oxide-eluting and REDV peptide-conjugated coating promotes vascular healing.
    Zhang B; Qin Y; Wang Y
    Biomaterials; 2022 May; 284():121478. PubMed ID: 35366606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercholesterolemia exacerbates in-stent restenosis in rabbits: Studies of the mitigating effect of stent surface modification with a CD47-derived peptide.
    Fishbein I; Inamdar VV; Alferiev IS; Bratinov G; Zviman MM; Yekhilevsky A; Nagaswami C; Gardiner KL; Levy RJ; Stachelek SJ
    Atherosclerosis; 2024 Mar; 390():117432. PubMed ID: 38241977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tough nitric oxide-eluting hydrogel coating suppresses neointimal hyperplasia on vascular stent.
    Chen Y; Gao P; Huang L; Tan X; Zhou N; Yang T; Qiu H; Dai X; Michael S; Tu Q; Huang N; Guo Z; Zhou J; Yang Z; Wu H
    Nat Commun; 2021 Dec; 12(1):7079. PubMed ID: 34873173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.
    Burzotta F; Brancati MF; Trani C; Porto I; Tommasino A; De Maria G; Niccoli G; Leone AM; Coluccia V; Schiavoni G; Crea F
    Trials; 2012 May; 13():55. PubMed ID: 22559260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Recovery in Bare Metal Stents and Drug-Eluting Stents on a Single-Cell Level.
    Cornelissen A; Guo L; Fernandez R; Kelly MC; Janifer C; Kuntz S; Sakamoto A; Jinnouchi H; Sato Y; Paek KH; Kolodgie FD; Romero ME; Surve D; Virmani R; Finn AV
    Arterioscler Thromb Vasc Biol; 2021 Aug; 41(8):2277-2292. PubMed ID: 34162228
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.